Lombard Odier Asset Management (USA)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.5M Hold
660,000
1.94% 10
2025
Q4
$16.4M Sell
660,000
-240,000
-27% -$6.05M 1.53% 16
2025
Q3
$22.9M Hold
900,000
1.54% 11
2025
Q2
$21.8M Hold
900,000
1.66% 14
2025
Q1
$22.8M Buy
900,000
+500,000
+125% +$13.1M 1.8% 12
2024
Q4
$10.6M Hold
400,000
0.78% 28
2024
Q3
$11.6M Hold
400,000
0.77% 32
2024
Q2
$11.2M Hold
400,000
0.83% 32
2024
Q1
$11.1M Buy
400,000
+200,000
+100% +$5.55M 0.27% 77
2023
Q4
$5.76M Hold
200,000
0.1% 130
2023
Q3
$6.63M Hold
200,000
0.15% 119
2023
Q2
$7.34M Hold
200,000
0.16% 107
2023
Q1
$8.16M Buy
200,000
+185,000
+1,233% +$7.99M 0.18% 84
2022
Q4
$769K Hold
15,000
0.02% 225
2022
Q3
$656K Hold
15,000
0.02% 241
2022
Q2
$786K Hold
15,000
0.03% 212
2022
Q1
$777K Hold
15,000
0.03% 190
2021
Q4
$886K Sell
15,000
-685,000
-98% -$33.9M 0.03% 188
2021
Q3
$30.1M Sell
700,000
-150,000
-18% -$6.65M 1.32% 16
2021
Q2
$33.3M Buy
850,000
+250,000
+42% +$9.72M 1.32% 18
2021
Q1
$21.7M Buy
+600,000
New +$21.3M 0.8% 26
2018
Q2
Sell
-44,795
Closed -$1.51M 282
2018
Q1
$1.51M Buy
+44,795
New +$1.54M 0.11% 158
2017
Q3
Sell
-61,132
Closed -$1.95M 244
2017
Q2
$1.95M Buy
61,132
+60,921
+28,873% +$1.92M 0.15% 145
2017
Q1
$684K Sell
211
-31,409
-99% -$990K 0.06% 182
2016
Q4
$974K Buy
+31,620
New +$965K 0.12% 134
2016
Q2
Sell
-422
Closed -$1.19M 236
2016
Q1
$1.19M Buy
+422
New +$12.1K 0.16% 128

Other funds holding PFE

Lombard Odier Asset Management (USA)'s PFE Position: Q3 2017 in Review

Lombard Odier Asset Management (USA) sold out of Pfizer (PFE) in Q3 2017, closing a stake of 19,499 shares — an estimated $621K sold.

Lombard Odier Asset Management (USA) first reported a position in PFE in Q3 2015 and held it in 4 quarters. The position peaked at $5.91M in Q3 2015. 2,041 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

  • Lombard Odier Asset Management (USA) reported no remaining Pfizer position as of Q3 2017 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 19,499 Pfizer shares in Q3 2017, an estimated $621K.
  • Lombard Odier Asset Management (USA) first reported a position in Pfizer in Q3 2015 and held it in 4 quarters.
  • Lombard Odier Asset Management (USA)'s Pfizer position peaked at $5.91M in Q3 2015.
  • 2,041 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q3 2017, filed 14 Nov 2017.